Back to Search Start Over

Orphan GPR116 mediates the insulin sensitizing effects of the hepatokine FNDC4 in adipose tissue

Authors :
Georgiadi, Anastasia
Lopez-Salazar, Valeria
Merahbi, Rabih El
Karikari, Rhoda Anane
Ma, Xiaochuan
Mourão, André
Klepac, Katarina
Bühler, Lea
Alfaro, Ana Jimena
Kaczmarek, Isabell
Linford, Adam
Bosma, Madeleen
Shilkova, Olga
Ritvos, Olli
Nakamura, Nobuhiro
Hirose, Shigehisa
Lassi, Maximilian
Teperino, Raffaele
Machado, Juliano
Scheideler, Marcel
Dietrich, Arne
Geerlof, Arie
Feuchtinger, Annette
Blutke, Andreas
Fischer, Katrin
Müller, Timo Dirk
Kessler, Katharina
Schöneberg, Torsten
Thor, Doreen
Hornemann, Silke
Kruse, Michael
Nawroth, Peter
Pivovarova-Ramich, Olga
Pfeiffer, Andreas Friedrich Hermann
Sattler, Michael
Blüher, Matthias
Herzig, Stephan
Publisher :
Apollo - University of Cambridge Repository

Abstract

Funder: European Foundation for the Study of Diabetes (EFSD); doi: https://doi.org/10.13039/501100001648<br />The proper functional interaction between different tissues represents a key component in systemic metabolic control. Indeed, disruption of endocrine inter-tissue communication is a hallmark of severe metabolic dysfunction in obesity and diabetes. Here, we show that the FNDC4-GPR116, liver-white adipose tissue endocrine axis controls glucose homeostasis. We found that the liver primarily controlled the circulating levels of soluble FNDC4 (sFNDC4) and lowering of the hepatokine FNDC4 led to prediabetes in mice. Further, we identified the orphan adhesion GPCR GPR116 as a receptor of sFNDC4 in the white adipose tissue. Upon direct and high affinity binding of sFNDC4 to GPR116, sFNDC4 promoted insulin signaling and insulin-mediated glucose uptake in white adipocytes. Indeed, supplementation with FcsFNDC4 in prediabetic mice improved glucose tolerance and inflammatory markers in a white-adipocyte selective and GPR116-dependent manner. Of note, the sFNDC4-GPR116, liver-adipose tissue axis was dampened in (pre) diabetic human patients. Thus our findings will now allow for harnessing this endocrine circuit for alternative therapeutic strategies in obesity-related pre-diabetes.

Details

Database :
OpenAIRE
Accession number :
edsair.doi...........fcbe533da868e71211f60c6106b9641f